Archive

New Ebola virus research boosts pandemic preparedness

Written by | 5 Mar 2025

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an […]

Antibody reduces allergic reactions to multiple foods in NIH trial

Written by | 24 Dec 2023

A monoclonal antibody treatment significantly increased the amounts of multiple common foods that food-allergic children and adolescents could consume without an allergic reaction, according to a planned interim […]

Current anti-COVID pills work well against omicron, but antibody drugs are less effective, study finds

Written by | 30 Jan 2022

The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study. However, […]

Mild COVID-19 induces lasting antibody protection, study finds

Written by | 4 Jun 2021

People who have had mild illness develop antibody-producing cells that can last lifetime Washington University School of Medicine Months after recovering from mild cases of COVID-19, people still […]

Stronger antibody response to more severe disease

Written by | 15 Nov 2020

Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease, […]

New vaccine could help halt Alzheimer’s progression

Written by | 12 Nov 2020

Our immune system’s capacity to mount a well-regulated defence against foreign substances, including toxins, weakens with age and makes vaccines less effective in people over age 65.. At […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.